Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Pediatric Infectious Diseases Physician in Jacksonville, FL
NPI: 1245299320Primary Practice Location
BAPTIST HEALTH MEDICAL CENTER - JACKSONVILLE
800 Prudential Dr, Jacksonville, FL
Primary Employer
University of Florida Jacksonville Physicians, Inc.
ufhealthjax.org
HQ Phone
Get M.D. Mobeen's Phone Numberphone_androidMobile
Get M.D. Mobeen's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
1991 - 2027
MD State Medical License
1986 - 1995
American Board of Pediatrics
Pediatric Infectious Diseases
SSM Health Cardinal Glennon Children’s Hospital
Pediatric Infectious Disease • 1988 - 1989
1988 - 1989
Akron Children's
Residency • Pediatrics
1985 - 1988
King Edward Medical University
Medical School
Until 1983
Oral acyclovir suppression and neurodevelopment after neonatal herpes.
Authors: Gregory Storch, David Kimberlin, Lisa Frenkel, Pablo Sanchez, Richard Whitley, Dwight Powell, Mark Shelton, Leonard Weiner, Rebecca Brady, Penelope Dennehy, Nazha Abughali
Journal: N Engl J Med
Authors: Rathore, M H, Chaban, C
Journal: Pediatr Infect Dis J
Authors: Isaac Delke, Coleen Cunningham, Robert Maupin
Journal: J Acquir Immune Defic Syndr
Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators: National Institute of Mental Health (NIMH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Intervention / Treatment: DRUG: Nevirapine (NVP), DRUG: Raltegravir (RAL), DRUG: DTG, DRUG: Nucleoside Reverse Transcriptase Inhibitors (NRTIs), DRUG: Lopinavir/Ritonavir (LPV/r), DRUG: VRC01, DRUG: VRC07-523LS
Lead Sponsor: Gilead Sciences
Intervention / Treatment: DRUG: Background regimen, DRUG: EVG
Lead Sponsor: Daniel Benjamin
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), The Emmes Company, LLC
Intervention / Treatment: DRUG: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
